BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8543464)

  • 1. Glucocorticoid receptors in depression.
    Pariante CM; Nemeroff CB; Miller AH
    Isr J Med Sci; 1995 Dec; 31(12):705-12. PubMed ID: 8543464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
    Cubała WJ; Landowski J
    Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
    Nemeroff CB
    J Clin Psychiatry; 1989 May; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].
    Juruena MF; Cleare AJ; Pariante CM
    Braz J Psychiatry; 2004 Sep; 26(3):189-201. PubMed ID: 15645065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior.
    Boyle MP; Brewer JA; Funatsu M; Wozniak DF; Tsien JZ; Izumi Y; Muglia LJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):473-8. PubMed ID: 15623560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P
    Acta Psychiatr Scand Suppl; 2000; (406):24-9. PubMed ID: 11131467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression.
    Heuser I
    Pharmacopsychiatry; 1998 Jan; 31(1):10-3. PubMed ID: 9524978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion.
    Spiga F; Harrison LR; Wood SA; Atkinson HC; MacSweeney CP; Thomson F; Craighead M; Grassie M; Lightman SL
    J Neuroendocrinol; 2007 Nov; 19(11):891-900. PubMed ID: 17927667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
    Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.